MeSH term
Count | 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 16 |
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 |
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/*pharmacology | 1 |
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/*antagonists & | 1 |
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/toxicity | 1 |
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/*metabolism | 2 |
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/pharmacology | 4 |
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/metabolism | 1 |
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic | 1 |
alpha-Linolenic Acid | 3 |
alpha-Linolenic Acid/metabolism | 1 |
alpha-Linolenic Acid/therapeutic use | 2 |
alpha-Linolenic Acid/chemistry | 1 |
alpha-Linolenic Acid/blood | 2 |
alpha-Linolenic Acid/pharmacology | 3 |
alpha-Linolenic Acid/toxicity | 1 |
alpha-Linolenic Acid/*therapeutic use | 1 |
alpha-Linolenic Acid/chemistry/*metabolism | 1 |
alpha-Linolenic Acid/blood/pharmacokinetics | 1 |
alpha-Linolenic Acid/administration & dosage/pharmacology | 1 |
alpha-Linolenic Acid/administration & dosage/*metabolism | 1 |
alpha-Linolenic Acid/*administration & dosage/pharmacology | 2 |
alpha-Linolenic Acid/administration & dosage/blood/*pharmacology | 1 |
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 6 |
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid/metabolism | 2 |
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid/*pharmacology | 1 |
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid/pharmacology | 4 |
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid/biosynthesis | 1 |
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid/biosynthesis/pharmacology | 1 |
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid/metabolism/pharmacology | 1 |
*alpha-MSH | 1 |
alpha-MSH/*pharmacology | 6 |
*alpha-Defensins | 1 |
*Alpha-Globulins | 1 |
alpha-MSH/immunology | 1 |
alpha-MSH/*physiology | 2 |
5-alpha-Dihydroprogesterone | 1 |
alpha-MSH/analysis | 1 |
*alpha Karyopherins | 5 |
alpha-Mannosidase | 10 |
alpha-MSH/*chemistry | 2 |
alpha 1-Antichymotrypsin | 8 |
alpha-MSH/blood | 2 |
17-alpha-Hydroxyprogesterone | 44 |
alpha-MSH/*blood | 3 |
alpha Karyopherins | 10 |
Alpha Rhythm | 15 |
*alpha-Fetoproteins | 6 |
alpha-MSH/*genetics | 1 |
*alpha 1-Antitrypsin | 1 |
*alpha-Macroglobulins | 5 |
*alpha-Galactosidase | 1 |
alpha-Fetoproteins | 3 |
*Alpha Particles | 5 |
alpha-MSH/pharmacology | 12 |
alpha-MSH/physiology | 6 |
alpha-MSH/metabolism | 15 |
Alpha-Globulins | 4 |
alpha-Glucosidases | 1 |
6-Ketoprostaglandin F1 alpha | 2 |
alpha-MSH/*metabolism | 5 |
Alpha Particles | 5 |
alpha 1-Antitrypsin | 10 |
*Alpha Rhythm | 4 |
alpha-MSH/genetics | 2 |
alpha-MSH/*immunology | 2 |
alpha-Methyltyrosine | 11 |
*alpha-Cyclodextrins | 1 |
alpha-N-Acetylgalactosaminidase | 9 |
alpha-Macroglobulins/blood | 3 |
alpha Karyopherins/*metabolism | 3 |
alpha-Fetoproteins/*deficiency | 1 |
alpha-Fetoproteins/chemistry | 3 |
*Pregnancy-Associated alpha 2-Macroglobulins | 1 |
PPAR alpha/*genetics | 1 |
alpha-MSH/metabolism/pharmacology | 4 |
6-Ketoprostaglandin F1 alpha/analysis | 3 |
alpha 1-Antichymotrypsin/*physiology | 2 |
alpha-Macroglobulins/*physiology | 3 |
alpha 1-Antitrypsin/*chemistry | 2 |
alpha-Glucosidases/urine | 1 |
Interferon-alpha/analysis | 10 |
Alpha-Globulins/urine | 4 |
alpha-L-Fucosidase/*genetics | 8 |
alpha-Galactosidase/*genetics | 7 |
alpha-MSH/isolation & purification | 1 |
*Adrenergic alpha-Antagonists | 1 |
Interferon-alpha/pharmacology | 95 |
*alpha-Fetoproteins/analysis | 9 |
6-Ketoprostaglandin F1 alpha/urine | 4 |
PPAR alpha/genetics | 3 |
alpha-L-Fucosidase/genetics | 2 |
Immunoglobulins, alpha-Chain | 1 |
alpha 1-Antichymotrypsin/analysis | 14 |
alpha-Tocopherol/*metabolism | 2 |
alpha-MSH/*immunology/metabolism | 1 |
alpha-Fetoproteins/secretion | 3 |
alpha-Glucosidases/*urine | 1 |
alpha-Glucosidases/*therapeutic use | 1 |
alpha-Tocopherol/*pharmacology | 2 |
